FFR? FFR-CT? Ischaemia testing?

Similar documents
Accuracy of the ST/HR hysteresis and of cardiopulmonary stress testing parameters in the diagnosis of exercise induced myocardial ischemia

FFR in Multivessel Disease

CT FFR: Are you ready to totally change the way you diagnose Coronary Artery Disease?

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Debate Should we use FFR? I will say NO.

ESC CONGRESS 2010 Stockholm, august 28 september 1, 2010

New Stable Chest Pain Guidance in the UK NICE to have, difficult to implement

Management of stable CAD FFR guided therapy: the new gold standard

Coronary interventions

FFR Incorporating & Expanding it s use in Clinical Practice

Fractional Flow Reserve from Coronary CT Angiography (and some neat CT images)

Benefit of Performing PCI Based on FFR

Fractional Flow Reserve (FFR)

FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators

CLINICAL CONSEQUENCES OF THE

Fractional Flow Reserve: Review of the latest data

Coronary stenting: the appropriate use of FFR

Physiology (FFR & IFR) is Essential in Daily Pratice. Martine Gilard Brest University - France

FRACTIONAL FLOW RESERVE Step-by-step measurement, Practical tips & Pitfalls

FFR-CT Not Ready for Primetime

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

The Latest on CT Fractional Flow Reserve. Dimitris Mitsouras, Ph.D.

VCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital

FRACTIONAL FLOW RESERVE USE IN THE CATH LAB BECAUSE ANGIOGRAPHY ALONE IS NOT ENOUGH!!!!!!!!

Coronary artery disease (CAD): Fractional Flow Reserve (FFR) for Pilots Risk Assessment. B. Haaff, R. Quast

Patient referral for elective coronary angiography: challenging the current strategy

Κλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE

Focus on Acute Coronary Syndromes

Stable Angina: Indication for revascularization and best medical therapy

Coronary Physiology the current state of play

What do the guidelines say?

Relations of Interest

Evaluating Clinical Risk and Guiding management with SPECT Imaging

FFR vs icecg in Coronary Bifurcations FIESTA ClinicalTrials.gov Identifier: NCT

Non merci! Revascularisation complète à la phase aigue de l infarctus? 8 e Cardiorun, La Réunion, 1 er octobre Gilles Rioufol, MD, PhD

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium

Σεμινάριο Ομάδων Εργασίας Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική

ROLE OF CORONARY PRESSURE & FFR IN MULTIVESSEL DISEASE

Imaging in Ischemic Heart Disease: Role of Cardiac MRI

FRACTIONAL FLOW RESERVE: STANDARD OF CARE

Technical Aspects and Clinical Indications of FFR

Disclosures. Speaker s bureau: Research grant: Advisory Board: Servier International, Bayer, Merck Serono, Novartis, Boehringer Ingelheim, Lupin

Coronary microvascular dysfunction after elective percutaneous coronary intervention: correlation with exercise stress test results

What the Cardiologist needs to know from Medical Images

Rational use of imaging for viability evaluation

Fractional Flow Reserve (FFR) --Practical Set Up Pressure Measurement --

FFR= Qs/Qn. Ohm s law R= P/Q Q=P/R

Pearls & Pitfalls in nuclear cardiology

Validation of CT Perfusion Imaging Against Invasive Angiography and FFR on a 320-MDCT Scanner

Clinical case in perspective. Cases from Poland

Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction

Which Test When? Avoid the Stress of Stress Testing. Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute

Current and Future Imaging Trends in Risk Stratification for CAD

Coronary Revascularization for Severe LV Dysfunction Is s. Is the concept of viability testing still viable?

Controversies in Coronary Revascularization. Atlanta CCU April 15, 2016

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

CASE from South Korea

Women and Coronary Artery Disease:

Risk Stratification for CAD for the Primary Care Provider

Fractional Flow Reserve (FFR) --Practical Set Up Pressure Measurement --

PCIs on Intermediate Lesions NCDR Cath-PCI Registry

CMR stress Perfusion: what's new?

Intervention: How and to which extent is technology helping us?

SPECT or PET for Cardiovascular Screening in High-Risk Patients

Typical chest pain with normal ECG

Declaration of conflict of interest. Nothing to disclose

SYNTAX III REVOLUTION Trial Press briefing conference. Prof. Patrick W. Serruys MD, PhD Principal Investigator Imperial College of London

Cardiology for the Practitioner Advanced Cardiac Imaging: Worth the pretty pictures?

Diagnostic Accuracy of Fractional Flow Reserve from Anatomic Computed TOmographic Angiography: The DeFACTO Study

Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users

STEMI AND MULTIVESSEL CORONARY DISEASE

Anatomy is Destiny, But Physiology is Here Today

The Future of Coronary Physiology

I have no financial disclosures

Dave Kettles, St Dominics Hospital East London.

PCI reduces death/myocardial infarction in stable patients with silent ischemia

FFR in unstable angina and after MI F

Assessment of Ischemia and Viability

Fractional Flow Reserve. A physiological approach to guide complex interventions

ECG in coronary artery disease. By Sura Boonrat Central Chest Institute

Clinical Considerations for CTO Revascularization

2/20/2013. Why use imaging in CV prevention? Update on coronary CTA in 2013 Coronary CTA for 1 0 prevention: pros and cons Are we there yet?

FFR-Guided PCI. 4 th Imaging and Physiology Summit October 29 th, 2010 Seoul, Korea. Stanford

Computed Tomography of the Coronary Arteries

3 Year Clinical Outcome and Cost-Effectiveness of FFR- Guided PCI in Stable Patients with Coronary Artery Disease: FAME 2 Trial

Le# Main Interven-on: When Is It Appropriate. Femi Philip, MD Assistant Professor Of Medicine UC Davis

CT or PET/CT for coronary artery disease

Noninvasive Fractional Flow Reserve from Coronary CT Angiography

Multisclice CT in combination with functional imaging for CAD. Temporal Resolution. Spatial Resolution. Temporal resolution = ½ of the rotation time

PCI vs. CABG From BARI to Syntax, Is The Game Over?

Angor Stable: de COURAGE à FAME 2. Maladie coronaire stable et coronarographie en De COURAGE à FAME 2

CARDIOLOGY GRAND ROUNDS

Cindy L. Grines MD FACC FSCAI

21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease

Thrombectomy. how? For whom?

The Role of Computed Tomography in the Diagnosis of Coronary Atherosclerosis

Controversies In STEMI Management

Can We Safely Defer PCI. Yes, already proven

J. Schwitter, MD, FESC Section of Cardiology

Transcription:

FFR? FFR-CT? Ischaemia testing? Marco Zimarino, MD, PhD Institute of Cardiology - University G. d Annunzio, Chieti (Italy)

Diagnostic management of patients with suspected stable CAD Risk stratification PTP > 85% PTP 50-85% PTP 15-50% PTP< 15% LV function Patients with suspected stable CAD LVEF <50% LVEF 50% Coronary CTA not available Invasive Coronary Angiography Stress imaging provided Patient suitability Local expertise Exercise ECG Test Coronary CTA provided Patient suitability Local expertise Investigate other causes Equivocal Lesion FFR-CT No lesion Ischemia + - Zimarino et al. J Cardiovasc Med 2017 (in press) modified from ESC guidelines on the management of stable CAD. Eur Heart J 2013

Rate of stress testing before PCI 44% of Medicare benificiaries underwent stress testing in the 90 days before elective PCI Lin GA, JAMA. 2008; 300: 1765-1773

Recommendations for the clinical value of intracoronary FFR ESC guidelines on the myocardial revascularization. Eur Heart J 2014

Fractional Flow Reserve (FFR) for the Functional Assessment of Coronary Stenosis Pijls NH et al. JACC 2012; 59: 1045 57

FFR measurement intracoronary adenosine bolus LCA : 600 µg RCA: 150 µg

FFR- vs Angio-guided PCI: persistence of 2-year outcome Pijls NH and the FAME investigators, JACC 2010; 56:177-84

PCI vs OMT in stable CAD patients with FFR 0.80 De Bruyne B and the FAME-2 investigators, NEJM 2014; 371:1208-17

FUnctional Testing Underlying REvascularization The FUTURE trial Rioful on behalf of FUTURE investigators, at AHA 2016

Results - as analyzed by the DSMB committee - Rioful on behalf of FUTURE investigators, at AHA 2016

Results - as halted by Sponsor and Steering committee - Rioful on behalf of FUTURE investigators, at AHA 2016

Anatomic vs Functional testing for CAD Douglas PS on behalf of PROMISE investigators, NEJM 2015

Fractional Flow Reserve derived from Computed Tomography (FFR-CT) Leber WA, Herz 2016 (in press)

FFR-CT in diffusely calcified coronary arteries Leber WA, Herz 2016 (in press)

Revascularisation strategy Complete anatomic revascularisation Myocardialspecific Lesionspecific An updated definition of Revascularization adequacy functionally adequate revascularization Definition Treatment of all coronary segments > 1.5 mm with a 50% DS irrespective of their ability to produce ischemia. Treatment of all coronary segments > 1.5 mm with a 50% DS supplying viable ischemic myocardium. Treatment of all coronary segments > 1.5 mm with a FFR<0.80. Incomplete revascularisation Inability or unsuitability to treat all coronary segments with significant disease (either 50% DS or FFR<0.80) supplying viable myocardium. Zimarino M et al. Int J Cardiol. 2013;168: 1748-57

Performance of non-invasive diagnostic methods used to make diagnosis of CAD ESC guidelines on the management of stable CAD. Eur Heart J 2013

ECG stress testing Basal Stress Recovery

ST/HR Hysteresis Normal Indicative of Myocardial Ischemia adapted from Okin PM et al. Circulation 1989;80:533 41

ST-T depression (mv) 0,2 ST/HR hysteresis 0,2 0,15 0,1 0,05 CAD - 0,15 0,1 0,05 CAD + 0-0,05 50 70 90 110 130 150 170 Heart Rate (bpm) -0,05 0 50 70 90 110 130 150 170 Heart Rate (bpm) Baseline 58 bpm Peak 157 bpm 1 Rec 122 bpm 5 Rec 83 bpm Baseline 55 bpm Peak 150 bpm 1 Rec 112 bpm 5 Rec 83 bpm Zimarino M. et al. J Cardiovasc Med 2017 (in press)

ST/HR Hysteresis and CPET AUC 95 % CI P ST/HR hysteresis 0.82 0.699 to 0.913 0.001 ST-max 0.68 0.542 to 0.798 NS VO 2 /Work b-b 1 slope 0.63 0.481 to 0.747 NS VO 2 /Work (aa 1 - bb 1 ) 0.61 0.474 to 0.740 NS Zimarino M. et al. Int J Cardiol 2013; 168: 1274 9

Left ventricular hypertrophy

ST/HR Hysteresis in patients with LVH * *all significance values are compared with the neutral test 0.5 AUC value. Zimarino M. et al. Eur J Prev Cardiol 2016; 23: 1632-9

Conclusions In pts with stable CAD (and with NSTE-ACS aside from culprit lesions) a thorough assessment of functional relevance of both myocardium and coronary severity is mandatory in most cases. FFR has a robust scientific evidence supporting its clinical relevance, although recently FFR-CT seems promising, but clinical translation of its relevance is needed. Good old exercise testing should not be abandoned in the current era of resource containment, as the adjunctive analysis of ST/HR hysteresis increases its diagnostic accuracy.